Vorinostat, an HDAC Inhibitor Attenuates Epidermoid Squamous Cell Carcinoma Growth by Dampening mTOR Signaling Pathway in a Human Xenograft Murine Model

Lignende værker

• Metformin, an anti-diabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway
  af: Chaudhary, Sandeep C., et al.
  Udgivet: (2012)
• Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy
  af: Park, Haeseong, et al.
  Udgivet: (2016)
• Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors
  af: Zibelman, Matthew, et al.
  Udgivet: (2015)
• SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas
  af: Kim, Arianna L., et al.
  Udgivet: (2018)
• Erb-041, an estrogen receptor beta agonist inhibits skin photocarcinogenesis in SKH-1 hairless mice by down-regulating WNT signaling pathway
  af: Chaudhary, Sandeep C, et al.
  Udgivet: (2013)